J&J
J&J

J&J Invests $2bn in Game-Changing Cancer Treatments
BIOT
🔍 Johnson & Johnson acquires Ambrx for $2bn to boost its ADC pipeline and advance innovative cancer treatments. 💼🌐💉
J&J

🔍 Johnson & Johnson acquires Ambrx for $2bn to boost its ADC pipeline and advance innovative cancer treatments. 💼🌐💉